TERM ID="NYU_TERM_1" STRING="Gene therapy" FREQUENCY=1 START=345 END=357 LEMMA="GENE THERAPY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_2" STRING="NB" FREQUENCY=2 START=515 END=517 LEMMA="NEUROBLASTOMA" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_3" STRING="NB" FREQUENCY=2 START=840 END=842 LEMMA="NEUROBLASTOMA" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_4" STRING="TAAs" FREQUENCY=1 START=208 END=212 LEMMA="TUMOR ASSOCIATED ANTIGENS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_5" STRING="antigens" FREQUENCY=1 START=198 END=206 LEMMA="ANTIGEN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_6" STRING="clinical trials" FREQUENCY=1 START=820 END=835 LEMMA="CLINICAL TRIAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_7" STRING="clinical trials for NB" FREQUENCY=1 START=820 END=842 LEMMA="NEUROBLASTOMA CLINICAL TRIAL" LEMMA_FREQUENCY=1 HEAD_TERM="clinical trials" HEAD_LEMMA="CLINICAL TRIAL"
TERM ID="NYU_TERM_8" STRING="driving tumor cells" FREQUENCY=1 START=432 END=451 LEMMA="DRIVING TUMOR CELL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_9" STRING="gene therapy" FREQUENCY=1 START=36 END=48 LEMMA="GENE THERAPY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_10" STRING="immuno-gene therapy" FREQUENCY=1 START=875 END=894 LEMMA="IMMUNO-GENE THERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_11" STRING="immuno-gene therapy strategies" FREQUENCY=1 START=784 END=814 LEMMA="IMMUNO-GENE THERAPY STRATEGY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_12" STRING="immunotherapy" FREQUENCY=1 START=18 END=31 LEMMA="IMMUNOTHERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_13" STRING="metastatic NB cases" FREQUENCY=1 START=648 END=667 LEMMA="METASTATIC NB CASE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_14" STRING="multimodality chemotherapy regimens" FREQUENCY=1 START=715 END=750 LEMMA="MULTIMODALITY CHEMOTHERAPY REGIMEN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_15" STRING="neoplastic phenotype" FREQUENCY=1 START=408 END=428 LEMMA="NEOPLASTIC PHENOTYPE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_16" STRING="neuroblastoma" FREQUENCY=2 START=500 END=513 LEMMA="NEUROBLASTOMA" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_17" STRING="neuroblastoma" FREQUENCY=2 START=500 END=513 LEMMA="NEUROBLASTOMA" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_18" STRING="neuroblastoma Immunotherapy" FREQUENCY=1 START=52 END=79 LEMMA="NEUROBLASTOMA IMMUNOTHERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_19" STRING="potential therapy" FREQUENCY=1 START=250 END=267 LEMMA="POTENTIAL THERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_20" STRING="risk disease" FREQUENCY=1 START=608 END=620 LEMMA="RISK DISEASE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_21" STRING="self-destruction" FREQUENCY=1 START=455 END=471 LEMMA="SELF-DESTRUCTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_22" STRING="survival rates" FREQUENCY=1 START=482 END=496 LEMMA="SURVIVAL RATE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_23" STRING="survival rates of neuroblastoma" FREQUENCY=1 START=482 END=513 LEMMA="NEUROBLASTOMA SURVIVAL RATE" LEMMA_FREQUENCY=1 HEAD_TERM="survival rates" HEAD_LEMMA="SURVIVAL RATE"
TERM ID="NYU_TERM_24" STRING="tumor-associated antigens" FREQUENCY=1 START=181 END=206 LEMMA="TUMOR-ASSOCIATED ANTIGEN" LEMMA_FREQUENCY=1
